Smital Shah
CIK 1808821 · Chief Fin. and Bus. Officer · last filed 2026-03-16
Smital Shah is a Chief Fin. and Bus. Officer who has filed 8 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for LYEL, was dated Mar 16, 2026. Across all open-market trades the lifetime net is +$100.0K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
8
$100.0K
Holdings By Company
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-16 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2023-07-21 | LENZ Therapeutics, Inc. (GRPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | LENZ Therapeutics, Inc. (GRPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2021-07-01 | LENZ Therapeutics, Inc. (GRPH) Delisted | Mixed | +5,882 | $100.0K | EDGAR |
| 2021-06-30 | PLRX | Grant (A) | — | $0 | EDGAR |